{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T06:07:55Z","timestamp":1791266875632,"version":"4.1.0"},"reference-count":80,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,9,1]],"date-time":"2014-09-01T00:00:00Z","timestamp":1409529600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,6,4]],"date-time":"2014-06-04T00:00:00Z","timestamp":1401840000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Fonds de Recherche en Sant\u00e9 du Qu\u00e9bec"},{"DOI":"10.13039\/501100000024","name":"Canadian Institute of Health Research","doi-asserted-by":"crossref","award":["MOP-199321"],"award-info":[{"award-number":["MOP-199321"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","neurobiologyofaging.org","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Aging"],"published-print":{"date-parts":[[2014,9]]},"DOI":"10.1016\/j.neurobiolaging.2014.03.037","type":"journal-article","created":{"date-parts":[[2014,5,15]],"date-time":"2014-05-15T16:15:49Z","timestamp":1400170549000},"page":"S3-S10","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":90,"special_numbering":"S2","title":["Apolipoprotein E and lipid homeostasis in the etiology and treatment of sporadic Alzheimer's disease"],"prefix":"10.1016","volume":"35","author":[{"given":"Judes","family":"Poirier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin","family":"Miron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1107-6839","authenticated-orcid":false,"given":"Cynthia","family":"Picard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Gormley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louise","family":"Th\u00e9roux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Breitner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doris","family":"Dea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neurobiolaging.2014.03.037_bib1","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1046\/j.1460-9568.2003.02869.x","article-title":"Non-steroidal anti-inflammatory drugs mediate increased in\u00a0vitro glial expression of apolipoprotein E protein","volume":"18","author":"Aleong","year":"2003","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neurobiolaging.2014.03.037_bib2","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.jalz.2010.01.009","article-title":"2010 Alzheimer's disease facts and figures","volume":"6","year":"2010","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.neurobiolaging.2014.03.037_bib3","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1007\/BF00405003","article-title":"Relationship between serum pseudocholinesterase and triglycerides in experimentally induced diabetes mellitus in rats","volume":"34","author":"Annapurna","year":"1991","journal-title":"Diabetologia"},{"key":"10.1016\/j.neurobiolaging.2014.03.037_bib4","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1523\/JNEUROSCI.17-02-00516.1997","article-title":"Plastic neuronal remodeling is impaired in patients with Alzheimer's disease carrying apolipoprotein epsilon 4 allele","volume":"17","author":"Arendt","year":"1997","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neurobiolaging.2014.03.037_bib5","doi-asserted-by":"crossref","first-page":"6771","DOI":"10.1523\/JNEUROSCI.0887-09.2009","article-title":"Human APOE isoform-dependent effects on brain beta-amyloid levels in PDAPP transgenic mice","volume":"29","author":"Bales","year":"2009","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neurobiolaging.2014.03.037_bib6","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0006-8993(99)01894-6","article-title":"Apolipoprotein E and beta-amyloid levels in the hippocampus and frontal cortex of Alzheimer's disease subjects are disease-related and apolipoprotein E genotype dependent","volume":"843","author":"Beffert","year":"1999","journal-title":"Brain Res."},{"key":"10.1016\/j.neurobiolaging.2014.03.037_bib7","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0165-0173(98)00008-3","article-title":"The neurobiology of apolipoproteins and their receptors in the CNS and Alzheimer's disease","volume":"27","author":"Beffert","year":"1998","journal-title":"Brain Res. Rev."},{"key":"10.1016\/j.neurobiolaging.2014.03.037_bib8","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1194\/jlr.R300017-JLR200","article-title":"Functions of lipoprotein receptors in neurons","volume":"45","author":"Beffert","year":"2003","journal-title":"J.\u00a0Lipid Res."},{"key":"10.1016\/j.neurobiolaging.2014.03.037_bib9","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/ng1934","article-title":"Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database","volume":"39","author":"Bertram","year":"2007","journal-title":"Nat. Genet."},{"key":"10.1016\/j.neurobiolaging.2014.03.037_bib10","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/0169-328X(95)00097-C","article-title":"Association of apolipoprotein-E genotype with brain levels of apolipoprotein-E and apolipoprotein J in Alzheimer's disease","volume":"33","author":"Bertrand","year":"1995","journal-title":"Mol. Brain Res."},{"key":"10.1016\/j.neurobiolaging.2014.03.037_bib11","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.jstrokecerebrovasdis.2010.11.002","article-title":"Statins, risk of dementia, and cognitive function: secondary analysis of the Ginkgo evaluation of memory study","volume":"21","author":"Bettermann","year":"2011","journal-title":"J.\u00a0Stroke Cerebrovasc. Dis."},{"key":"10.1016\/j.neurobiolaging.2014.03.037_bib12","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0764-4469(00)01274-9","article-title":"A\u00a0study of French centenarians: are ACE and APOE associated with longevity?","volume":"324","author":"Blanche","year":"2001","journal-title":"C.\u00a0R. Acad. Sci. III"},{"key":"10.1016\/j.neurobiolaging.2014.03.037_bib13","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1523\/JNEUROSCI.4315-03.2004","article-title":"Neuron-specific apolipoprotein e4 proteolysis is associated with increased tau phosphorylation in brains of transgenic mice","volume":"24","author":"Brecht","year":"2004","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neurobiolaging.2014.03.037_bib14","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/S0306-4522(02)00313-5","article-title":"Apolipoprotein E knockout mice display procedural deficits in the Morris water maze: analysis of learning strategies in three versions of the task","volume":"114","author":"Champagne","year":"2002","journal-title":"Neuroscience"},{"key":"10.1016\/j.neurobiolaging.2014.03.037_bib15","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0306-4522(03)00361-0","article-title":"The cholesterol-lowering drug probucol increases apolipoprotein E production in the hippocampus of aged rats: implications for Alzheimer's disease","volume":"121","author":"Champagne","year":"2003","journal-title":"Neuroscience"},{"key":"10.1016\/j.neurobiolaging.2014.03.037_bib16","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.expneurol.2005.01.016","article-title":"Effect of apolipoprotein E deficiency on reactive sprouting in the dentate gyrus of the hippocampus following entorhinal cortex lesion: role of the astroglial response","volume":"194","author":"Champagne","year":"2005","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neurobiolaging.2014.03.037_bib17","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/S0306-4522(00)00087-7","article-title":"Reversal of presynaptic deficits of apolipoprotein E-deficient mice in human apolipoprotein E transgenic mice","volume":"97","author":"Chapman","year":"2000","journal-title":"Neuroscience"},{"key":"10.1016\/j.neurobiolaging.2014.03.037_bib18","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1038\/ng0694-180","article-title":"Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease","volume":"7","author":"Corder","year":"1994","journal-title":"Nat. Genet."},{"key":"10.1016\/j.neurobiolaging.2014.03.037_bib19","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/S1474-4422(05)70022-3","article-title":"The Women's Health Initiative Memory Study: findings and implications for treatment","volume":"4","author":"Craig","year":"2005","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.neurobiolaging.2014.03.037_bib20","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1126\/science.1217697","article-title":"ApoE-directed therapeutics rapidly clear beta-amyloid and reverse deficits in AD mouse models","volume":"335","author":"Cramer","year":"2012","journal-title":"Science"},{"key":"10.1016\/j.neurobiolaging.2014.03.037_bib21","doi-asserted-by":"crossref","first-page":"4558","DOI":"10.1093\/hmg\/dds296","article-title":"Cerebrospinal fluid APOE levels: an endophenotype for genetic studies for Alzheimer's disease","volume":"21","author":"Cruchaga","year":"2012","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neurobiolaging.2014.03.037_bib22","first-page":"48","article-title":"Experience with probucol in the treatment of hypercholesterolemia","volume":"10","author":"Davignon","year":"1982","journal-title":"Artery"},{"key":"10.1016\/j.neurobiolaging.2014.03.037_bib23","first-page":"9","article-title":"Evolution of the human lifespan, past, present, and future: phases in the evolution of human life expectancy in relation to the inflammatory load","volume":"156","author":"Finch","year":"2012","journal-title":"Proc. Am. Philos. Soc."},{"key":"10.1016\/j.neurobiolaging.2014.03.037_bib24","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S0197-4580(99)00053-6","article-title":"The evolution of Alzheimer disease, the reproductive schedule, and apoE isoforms","volume":"20","author":"Finch","year":"1999","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neurobiolaging.2014.03.037_bib25","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1126\/science.1235809","article-title":"ApoE-directed therapeutics rapidly clear beta-amyloid and reverse deficits in AD mouse models","volume":"340","author":"Fitz","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.neurobiolaging.2014.03.037_bib26","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1212\/WNL.52.2.244","article-title":"Apolipoprotein E-epsilon4 genotype predicts a poor outcome in survivors of traumatic brain injury","volume":"52","author":"Friedman","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2014.03.037_bib27","doi-asserted-by":"crossref","first-page":"M75","DOI":"10.1093\/gerona\/56.2.M75","article-title":"Longevity and the epsilon2 allele of apolipoprotein E: the Finnish Centenarians Study","volume":"56","author":"Frisoni","year":"2001","journal-title":"J.\u00a0Gerontol. A Biol. Sci. Med. Sci."},{"key":"10.1016\/j.neurobiolaging.2014.03.037_bib28","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1086\/303070","article-title":"Apolipoprotein E variation at the sequence haplotype level: implications for the origin and maintenance of a major human polymorphism","volume":"67","author":"Fullerton","year":"2000","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.neurobiolaging.2014.03.037_bib29","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1038\/mp.2011.52","article-title":"APOE and Alzheimer disease: a major gene with semi-dominant inheritance","volume":"16","author":"Genin","year":"2011","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.neurobiolaging.2014.03.037_bib30","series-title":"Cholinesterases and Cholinesterase Inhibitors. Basic, Preclinical and Clinical Aspects","author":"Giacobini","year":"2000"},{"key":"10.1016\/j.neurobiolaging.2014.03.037_bib31","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1016\/S0306-4522(02)00178-1","article-title":"Genotype-related differences of hippocampal apolipoprotein E levels only in early stages of neuropathological changes in Alzheimer's disease","volume":"114","author":"Glockner","year":"2002","journal-title":"Neuroscience"},{"key":"10.1016\/j.neurobiolaging.2014.03.037_bib32","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/BF02815210","article-title":"Biochemical and cognitive studies of apolipoprotein-E-deficient mice","volume":"28","author":"Gordon","year":"1996","journal-title":"Mol. Chem. Neuropathol."},{"key":"10.1016\/j.neurobiolaging.2014.03.037_bib33","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1212\/WNL.0b013e318211c352","article-title":"Plasma apolipoprotein E and Alzheimer disease risk: the AIBL study of aging","volume":"76","author":"Gupta","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2014.03.037_bib34","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/0021-9150(94)05402-5","article-title":"Arginine residues at codons 112 and 158 in the apolipoprotein E gene correspond to the ancestral state in humans","volume":"112","author":"Hanlon","year":"1995","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.neurobiolaging.2014.03.037_bib35","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1038\/ng.440","article-title":"Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease","volume":"41","author":"Harold","year":"2009","journal-title":"Nat. Genet."},{"key":"10.1016\/j.neurobiolaging.2014.03.037_bib36","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/35036221","article-title":"Apolipoprotein E receptors: linking brain development and Alzheimer's disease","volume":"1","author":"Herz","year":"2000","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neurobiolaging.2014.03.037_bib37","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1191\/135245800678827851","article-title":"Apoliprotein E and multiple sclerosis: impact of the epsilon-4 allele on susceptibility, clinical type and progression rate","volume":"6","author":"Hogh","year":"2000","journal-title":"Mult. Scler."},{"key":"10.1016\/j.neurobiolaging.2014.03.037_bib38","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.2169\/internalmedicine.46.0049","article-title":"Serum butyrylcholinesterase is strongly associated with adiposity, the serum lipid profile and insulin resistance","volume":"46","author":"Iwasaki","year":"2007","journal-title":"Intern. Med."},{"key":"10.1016\/j.neurobiolaging.2014.03.037_bib39","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1016\/S0140-6736(00)03155-X","article-title":"Statins and the risk of dementia","volume":"356","author":"Jick","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.neurobiolaging.2014.03.037_bib40","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.neuron.2009.06.026","article-title":"The role of apolipoprotein E in Alzheimer's disease","volume":"63","author":"Kim","year":"2009","journal-title":"Neuron"},{"key":"10.1016\/j.neurobiolaging.2014.03.037_bib41","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/S0736-5748(98)00084-7","article-title":"The effects of apolipoprotein E deficiency on brain cholinergic neurons","volume":"16","author":"Kleifeld","year":"1998","journal-title":"Int. J. Develop. Neurosci."},{"key":"10.1016\/j.neurobiolaging.2014.03.037_bib42","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1016\/S0306-4522(99)00061-5","article-title":"Cholinergic systems and long-term potentiation in memory-impaired apolipoprotein E-deficient mice","volume":"92","author":"Krzywkowski","year":"1999","journal-title":"Neuroscience"},{"key":"10.1016\/j.neurobiolaging.2014.03.037_bib43","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1038\/ng.439","article-title":"Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease","volume":"41","author":"Lambert","year":"2009","journal-title":"Nat. Genet."},{"key":"10.1016\/j.neurobiolaging.2014.03.037_bib44","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.molmed.2010.07.008","article-title":"APOE and cholesterol homeostasis in Alzheimer's disease","volume":"16","author":"Leduc","year":"2010","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.neurobiolaging.2014.03.037_bib45","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1212\/01.WNL.0000128089.53030.AC","article-title":"Apolipoprotein E controls the risk and age at onset of Parkinson disease","volume":"62","author":"Li","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2014.03.037_bib46","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1212\/WNL.55.10.1536","article-title":"Apolipoprotein E and functional recovery from brain injury following postacute rehabilitation","volume":"55","author":"Lichtman","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2014.03.037_bib47","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/0896-6273(90)90342-D","article-title":"Dynamics of gene expression for a hippocampal glycoprotein elevated in Alzheimer's disease and in response to experimental lesions in rat","volume":"5","author":"May","year":"1990","journal-title":"Neuron"},{"key":"10.1016\/j.neurobiolaging.2014.03.037_bib48","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1038\/nrm3151","article-title":"Molecular mechanism and physiological functions of clathrin-mediated endocytosis","volume":"12","author":"McMahon","year":"2011","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.neurobiolaging.2014.03.037_bib49","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1161\/01.ATV.11.3.476","article-title":"Increase in plasma cholesteryl ester transfer protein during probucol treatment. Relation to changes in high density lipoprotein composition","volume":"11","author":"McPherson","year":"1991","journal-title":"Arterioscler. Thromb."},{"key":"10.1016\/j.neurobiolaging.2014.03.037_bib50","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1111\/j.1749-6632.1996.tb34431.x","article-title":"Amyloid beta-protein, APOE genotype and head injury","volume":"777","author":"Nicoll","year":"1996","journal-title":"Ann. N.Y. Acad. Sci."},{"key":"10.1016\/j.neurobiolaging.2014.03.037_bib51","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0006-8993(96)01448-5","article-title":"Severe learning deficits in apolipoprotein E knockout mice in a water maze task","volume":"752","author":"Oitzl","year":"1997","journal-title":"Brain Res."},{"key":"10.1016\/j.neurobiolaging.2014.03.037_bib52","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s11745-011-3595-4","article-title":"Probucol suppresses enterocytic accumulation of amyloid-\u03b2 induced by saturated fat and cholesterol feeding","volume":"47","author":"Pallebage-Gamarallage","year":"2012","journal-title":"Lipids"},{"key":"10.1016\/j.neurobiolaging.2014.03.037_bib53","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1097\/00001756-200303240-00016","article-title":"Apolipoprotein E (APOE) polymorphism influences serum APOE levels in Alzheimer's disease patients and centenarians","volume":"14","author":"Panza","year":"2003","journal-title":"Neuroreport"},{"key":"10.1016\/j.neurobiolaging.2014.03.037_bib54","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/0166-2236(94)90156-2","article-title":"Apolipoprotein E in animal models of CNS injury and in Alzheimer's disease","volume":"17","author":"Poirier","year":"1994","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.neurobiolaging.2014.03.037_bib55","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/S1471-4914(03)00007-8","article-title":"Apolipoprotein E and cholesterol metabolism in the pathogenesis and treatment of Alzheimer's disease","volume":"9","author":"Poirier","year":"2003","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.neurobiolaging.2014.03.037_bib57","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.neurobiolaging.2004.09.003","article-title":"Apolipoprotein E, cholesterol transport and synthesis in sporadic Alzheimer's disease","volume":"26","author":"Poirier","year":"2005","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neurobiolaging.2014.03.037_bib58","doi-asserted-by":"crossref","first-page":"S91","DOI":"10.1016\/j.jalz.2007.11.012","article-title":"Apolipoprotein E represents a potent gene-based therapeutic target for the treatment of sporadic Alzheimer's disease","volume":"4","author":"Poirier","year":"2008","journal-title":"J.\u00a0Alzheimers. Dement."},{"key":"10.1016\/j.neurobiolaging.2014.03.037_bib59","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/0140-6736(93)91705-Q","article-title":"Apolipoprotein E polymorphism and Alzheimer's disease","volume":"342","author":"Poirier","year":"1993","journal-title":"Lancet"},{"key":"10.1016\/j.neurobiolaging.2014.03.037_bib60","doi-asserted-by":"crossref","first-page":"12260","DOI":"10.1073\/pnas.92.26.12260","article-title":"Apolipoprotein E4 allele as a predictor of cholinergic deficits and treatment outcome in Alzheimer disease","volume":"92","author":"Poirier","year":"1995","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.neurobiolaging.2014.03.037_bib61","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/0169-328X(91)90111-A","article-title":"Astrocytic apolipoprotein E mRNA and GFAP mRNA in hippocampus after entorhinal cortex lesioning","volume":"11","author":"Poirier","year":"1991","journal-title":"Brain Res. Mol. Brain Res."},{"key":"10.1016\/j.neurobiolaging.2014.03.037_bib62","first-page":"36","article-title":"Apolipoprotein E: a novel therapeutic target for the treatment of Alzheimer's disease","volume":"51","author":"Poirier","year":"2002","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.neurobiolaging.2014.03.037_bib63","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/S0022-2275(20)39705-4","article-title":"Adipose tissue cholesteryl ester transfer protein mRNA in response to probucol treatment: cholesterol and species dependence","volume":"34","author":"Quinet","year":"1993","journal-title":"J.\u00a0Lipid Res."},{"key":"10.1016\/j.neurobiolaging.2014.03.037_bib64","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1038\/mp.2013.19","article-title":"APOE and BCHE as modulators of cerebral amyloid deposition: a florbetapir PET genome-wide association study","volume":"19","author":"Ramanan","year":"2014","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.neurobiolaging.2014.03.037_bib65","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.mcn.2007.01.011","article-title":"The LXR agonist TO901317 selectively lowers hippocampal Abeta42 and improves memory in the Tg2576 mouse model of Alzheimer's disease","volume":"34","author":"Riddell","year":"2007","journal-title":"Mol. Cell Neurosci."},{"key":"10.1016\/j.neurobiolaging.2014.03.037_bib66","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1212\/WNL.43.8.1609","article-title":"Clinical trial of indomethacin in Alzheimer's disease","volume":"43","author":"Rogers","year":"1993","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2014.03.037_bib67","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/j.expneurol.2011.11.036","article-title":"Probucol, a lipid-lowering drug, prevents cognitive and hippocampal synaptic impairments induced by amyloid beta peptide in mice","volume":"233","author":"Santos","year":"2012","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neurobiolaging.2014.03.037_bib68","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1001\/jama.2010.574","article-title":"Genome-wide analysis of genetic loci associated with Alzheimer disease","volume":"303","author":"Seshadri","year":"2010","journal-title":"JAMA"},{"key":"10.1016\/j.neurobiolaging.2014.03.037_bib69","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1001\/jama.1997.03540340052032","article-title":"Apolipoprotein E epsilon4 and the risk of dementia with stroke. A population-based investigation","volume":"277","author":"Slooter","year":"1997","journal-title":"JAMA"},{"key":"10.1016\/j.neurobiolaging.2014.03.037_bib70","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1001\/archneurol.2012.1070","article-title":"Plasma biomarkers associated with the apolipoprotein E genotype and Alzheimer disease","volume":"69","author":"Soares","year":"2012","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.neurobiolaging.2014.03.037_bib71","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1038\/nm0995-852","article-title":"ApoE as a prognostic factor for post-traumatic coma","volume":"1","author":"Sorbi","year":"1995","journal-title":"Nat. Med."},{"key":"10.1016\/j.neurobiolaging.2014.03.037_bib72","doi-asserted-by":"crossref","first-page":"8098","DOI":"10.1073\/pnas.90.17.8098","article-title":"Binding of human apolipoprotein E to synthetic amyloid beta peptide: isoform-specific effects and implications for late-onset Alzheimer disease","volume":"90","author":"Strittmatter","year":"1993","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"10.1016\/j.neurobiolaging.2014.03.037_bib73","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.neurobiolaging.2009.05.011","article-title":"Reduced levels of human apoE4 protein in an animal model of cognitive impairment","volume":"32","author":"Sullivan","year":"2009","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neurobiolaging.2014.03.037_bib74","first-page":"173","article-title":"Apolipoprotein E mutants, hyperlipidemia and arteriosclerosis","volume":"183","author":"Utermann","year":"1985","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.neurobiolaging.2014.03.037_bib75","first-page":"339","article-title":"Genetics of the apolipoprotein E system in man","volume":"32","author":"Utermann","year":"1980","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.neurobiolaging.2014.03.037_bib76","doi-asserted-by":"crossref","first-page":"30525","DOI":"10.1074\/jbc.M001151200","article-title":"A\u00a0protective role of the low density lipoprotein receptor-related protein against amyloid beta-protein toxicity","volume":"275","author":"Van Uden","year":"2000","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neurobiolaging.2014.03.037_bib77","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/S0304-3940(99)00243-8","article-title":"Differential neurotrophic effects of apolipoprotein E in aged transgenic mice","volume":"265","author":"Veinbergs","year":"1999","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neurobiolaging.2014.03.037_bib78","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/S0306-4522(98)00602-2","article-title":"Synaptic alterations in apolipoprotein E knockout mice","volume":"91","author":"Veinbergs","year":"1999","journal-title":"Neuroscience"},{"key":"10.1016\/j.neurobiolaging.2014.03.037_bib79","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/S0531-5565(00)00194-7","article-title":"Demography of longevity: past, present, and future trends","volume":"35","author":"Wilmoth","year":"2000","journal-title":"Exp. Gerontol."},{"key":"10.1016\/j.neurobiolaging.2014.03.037_bib80","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1001\/archneur.57.10.1439","article-title":"Decreased prevalence of Alzheimer disease associated with 3-hydroxy-3-methyglutaryl coenzyme A reductase inhibitors","volume":"57","author":"Wolozin","year":"2000","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.neurobiolaging.2014.03.037_bib81","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/1741-7015-5-20","article-title":"Simvastatin is associated with a reduced incidence of dementia and Parkinson's disease","volume":"5","author":"Wolozin","year":"2007","journal-title":"BMC Med."}],"container-title":["Neurobiology of Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458014003534?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458014003534?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,4,3]],"date-time":"2022-04-03T17:05:00Z","timestamp":1649005500000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0197458014003534"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9]]},"references-count":80,"alternative-id":["S0197458014003534"],"URL":"https:\/\/doi.org\/10.1016\/j.neurobiolaging.2014.03.037","relation":{},"ISSN":["0197-4580"],"issn-type":[{"value":"0197-4580","type":"print"}],"subject":[],"published":{"date-parts":[[2014,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Apolipoprotein E and lipid homeostasis in the etiology and treatment of sporadic Alzheimer's disease","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Aging","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurobiolaging.2014.03.037","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc.","name":"copyright","label":"Copyright"}]}}